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1. Introduction 
The study of the mechanisms regulating RNA syn- 
thesis in eukaryotes has led to the isolation of 
stimulating [l-5] and repressing factors [6-81 of 
RNA polymerases in vitro. Some of these factors have 
a narrow specificity: enzyme or template specificity. 
From Ehrlich ascites tumor cells, Natori et al. have 
isolated a factor repressing RNA polymerase II [6,7] . 
It is a ribonucleoprotein which inhibits the transcrip- 
tion of native DNA by homologous RNA polymerase II. 
A non histone protein isolated from Ehrlich cell 
chromatin inhibits the transcription of native DNA 
by eukaryotic RNA polymerase II. It inhibits preferen- 
tially the transcription of homologous DNA [8] . 
In this paper, we report the isolation from nuclei 
of Ehrlich ascites tumor cells of a protein factor 
which inhibits the transcription of native ascites DNA 
by mammalian RNA polymerase A or I (located in 
the nucleolus) and RNA polymerase B or II (located 
in the nucleoplasm). 
2. Materials and methods 
Materials and their sources were described 
previously [9] . 
2.1, Polymerase assay 
The assay mixture contains in 0.16 ml total 
volume, 62 .S mM of Tris-HCl pH 7.9,3 mM MnClz , 
18 pg DNA (350 mM), ammonium sulfate 75 mM, 
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0.25 mM ATP, GTP and CTP, 0.03 mM [3H]UTP 
(20-100 counts X min-’ X pmol-‘). Enzyme is 
added in the following buffer: 50 mM Tris-HCl 
pH 7.9, 10 mM thioglycerol, 0.1 mM EDTA, 0.1 mM 
dithio-1,4-erythritol, glycerol 30%, v/v. Assays were 
incubated for 20 min at 37°C and collected on a 
Whatman paper no 1 (4 X 4 cm). Whatman papers 
were washed 3 times with cold 5% perchloric acid, 
0.1 M sodium pyrophosphate, for a few hours and 
3 times with an ether-ethanol mixture (l/l). After 
drying for 10 min at 6O”C, papers were counted with a 
Beckman scintillation counter in vials containing 5 ml 
of scintillator (PPO 0.6%, w/v; POPOP 0.03%, w/v in 
toluene). Values of the blank assays (not incubated) 
were subtracted. A unit of enzyme activity is defined 
as the amount of enzyme required to incorporate 
1 pmol UTP/min of incubation under the conditions 
described above. All assays were made in duplicate. 
2.2. Assay of inhibition or stimulation of RNA 
synthesis 
Fractions to be tested, lo-100 ~1, were 
added to the assay mixture before incubation with 
enzymes. 
3. Results and discussion 
During the last step of the purification of ascites 
RNA polymerases [9] , the protein fractions eluted 
from the DEAE cellulose column were systematically 
tested for their repressing or stimulating activities 
towards ascites RNA polymerases A and B. No 
stimulating factor was detected. The material excluded 
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Fig.1. DEAE cellulose chromatography of inhibitory factor 
and of RNA polymerase A and B activities. DEAE cellulose 
column was equilibrated with the following buffer : 50 mM 
Tris-HCl, pH 7.9,lOmM thioglycerol, 0.1 mM EDTA, 0.1 mM 
dithio-1,4erythritol, 0.05 M ammonium sulfate, glycerol 
30%, v/v. 30 ml corresponding to 1-2 mg/ml of protein 
were loaded on the column (1.5 X 30 cm) at a flow rate of 
11-l 5 ml/h and allowed to stand for 1 h. The resin was 
washed with 50-100 ml of the buffer. Elution was performed 
with a linear 0.05-0.6 M ammonium sulfate gradient in 
300 ml of the buffer at a flow rate of 25 ml/h. Fractions of 
4 ml were collected and kept at -70°C. Enzyme activity is 
detected on aliquots (60 ~1) incubated with 1.25 Mg of 
cu-amanitin (inhibitor of RNA polymerase B) or without 
cy-amanitin. (e-0) A,,,; (m-m) ammonium sulfate 
gradient; (o-o) activity of RNA polymerase in the presence 
of ol-amanitin; (A-A) activity of RNA polymerase in the 
absence of a-amanitin; (a-~) inhibitor activity (30 ~1 of 
inhibitor A,,, = 0.4, with Ehrlich ascites RNA polymerase A 
and ascites DNA). 
on DEAE cellulose column strongly inhibits RNA 
polymerases A and B (fig.1). The inhibitory effect 
increases with factor concentration (fig.2). The 
activity of this factor has been tested with RNA 
polymerases A and B from Ehrlich ascites tumor cells 
and from calfthymus, using two different mammalian 
DNA templates: one is the homologous nuclei ascites 
DNA, which is composed of 90% of a main compo- 
nent (42% CC base pairs) and 10% of a light satellite 
(3 1.6% CC base pairs); the other one is the calf 
thymus DNA whose base composition is not very dif- 
ferent (44% CC base pairs). The calf genome contains 
at least 4 satellite DNAs which represent 15% of the 
total DNA. The kinetics of reassociation of ascites 
I 
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Fig.2. Inhibition of RNA polymerase B from Ehrlich ascites 
tumor cells by the inhibitory factor with native ascites DNA 
template. Ammonium sulfate concentration is maintained 
constant by addition of aliquots of 0.05 M ammonium 
sulfate. Concentration of the solution containing the 
inhibitory factor : A,,, = 0.4. 
tumor total DNA [lo] and calf thymus DNA [ 1 I] 
show that both DNAs have the same proportion of 
highly reiterated sequences. The molecular weight of 
nuclei ascites DNA varies, according to the different 
preparations, between 8.2 to 15.7 X lo6 and m the 
case of calf thymusDNA between 6 and 8 X 106. No 
single strand breaks can be detected either in ascites 
or in calf thymus DNA, by the technic of Sicard et al. 
[ 121 . Therefore, it seems relevant to compare the 
action of the inhibitory factor towards these two 
DNAs whose physico-chemical properties are similar. 
The results are summarized in table 1. This factor 
inhibits RNA synthesis with the four enzymes tested 
but only with ascites DNA template. The inhibition 
cannot be attributed to a degradation of newly syn- 
thesized RNA since the transcription of calf thymus 
DNA is not inhibited. 
The factor activity is destroyed by digestion 
(5 min, 37°C) with different amounts of trypsin. 
After cooling at 4”C, trypsin action is stopped by 
addition of soy bean trypsin inhibitor. The decrease 
of repressing activity is related to the quantity of 
trypsin added. The inhibitory activity is also sup- 
pressed by treatment with an equal volume of chloro- 
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Table 1 
Effect of the inhibitory factor on RNA synthesis by ascites 
or calf thymus RNA polymerases with ascites or calf thymus 
DNA templates 
RNA polymerase DNA 
Calf thymus Ascites 
Ascites A 104 30 
Ascites B 106 53 
Calf thymus A 90 58 
Calf thymus B 100 46 
% activity has been calculated with reference to DNA without 
inhibitor. Inhibitor concentration: 30 pl (A 2~o = 0.4) in the 
assay medium described in the text. 30 ~1 of the buffer con- 
taining 0.05 M ammonium sulfate are added in control assays 
form-isoamyl alcohol (9 : 1) which is a denaturing 
agent of proteins. 
Since some repressing factors are nucleoproteins 
[7,13], the presence of nucleic acid has been checked 
in this inhibitory factor. Incubation with endonuclease 
from Staphylococcus aureus is without action on the 
inhibitory activity. Furthermore no inorganic phos- 
phate has been detected after complete hydrolysis 
of the molecule. Therefore, it can be assumed that 
the inhibitory factor does not contain nucleic acid. 
In order to prove that the inhibitory activity is not 
due to a contamination by a nuclease destroying the 
DNA template, ascites DNA was incubated with the 
inhibitor and thereafter treated with an equal volume 
of chloroform-isoamyl alcohol (9:l). The DNA 
which is contained in the aqueous phase is precipitated 
by 2 volumes of cold ethanol and dialysed against the 
appropriate solvent. The yield of DNA is 100%. The 
physicochemical properties of the DNA are not modi- 
fied (table 2). The repressing activity can hardly be 
attributed to the very slight number of single strand 
breaks. This DNA is normally transcribed by RNA 
polymerases and the transcription can be inhibited 
by a subsequent addition of the inhibitor. 
In conclusion, it can be assumed that the inhibitory 
factor isolated from purified nuclei of Ehrlich ascites 
tumor cells inhibits selectively the transcription of 
homologous DNA. This factor is not enzyme specific 
since it inhibits RNA synthesis not only by RNA 
polymerase A and B from Ehrlich cells but also by 
RNA polymerases A and B from calf thymus. It does 
not interfere with another inhibitor of transcription, 
the antibiotic antimitotic daunorubicin. This drug 
interacts with DNA without base specificity and 
inhibits enzymic reactions (DNAases, RNA poly- 
merases) by formation of an inactive complex DNA- 
enzyme-daunorubicin [9 ,13 ,141. The presence of the 
protein inhibitor is without influence on the kinetics 
of inhibition of RNA synthesis by daunorubicin (flg.3). 
This factor is not a nucleoprotein, therefore 
it is different from the ribonucleoprotein factor 
characterized in [7] . As it inhibits the transcrip- 
tion by RNA polymerase A as well as the tran- 
scription by RNA polymerase B, it is also different 
from the non histone chromosomal protein factor 
Table 2 
Some physicochemical properties of ascites DNA before and after incubation 
with the inhibitory factor 
Ascites 
DNA 
Tm SN sA Single 
(0.1 SSC) EN 6 Zii 6 strand 
breaks 
Native 71.5 27.3 29.4 15.7 7.41 0 
After incubation 
with the inhibi- 70.5 26.8 24.0 14.9 4.41 0.68 
tory factor 
SN and SA; sedimentation constant in neutral or alkaline medium. MN (molec- 
ular weight in neutral medium, NaCl M) and MA (molecular weight in alkaline 
medium, 0.9 M NaCl-0.1 M NaOH) arc estimated according to Studier [ 131. 
Single strand breaks have been calculated according to Sicard et al. [ 121 
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Fig.3. Inhibition of RNA polymerase by daunorubicin in the 
absence or in the presence of the inhibitory factor. Results 
are expressed according to Reiner [ 131. The ordinate shows 
daunorubicin concentration and the abcissa i/l-i where i = 
(rate without daunorubicin - rate with daunorubicin)/(rate 
without daunorubicin). Incubation medium: MnCl,, 2 mM; 
(NH,),SO,,94 mM;ascitesDNAconcentration 1.2 X 10d4 M, 
50 ).d RNA polymerase B from Ehrlich ascites cells. (A-A) 
Without protein inhibitor; (O--O) in the presence of the 
protein inhibitor (30 &A,,, = 0.4) added in the incubation 
medium together with daunorubicin and before RNA 
polymerase. 
which is specific for eukaryotic RNA polymerase II 
and binds specifically to the reiterated sequences of 
the DNA [8]. Attempts to define the role of these 
repressing or stimulating factors can lead to a better 
knowledge of the mechanism of transcription by RNA 
polymerases not only in vitro, but moreover in vivo. 
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